Myocardial fat accumulation is associated with cardiac dysfunction in patients with type 2 diabetes, especially in elderly or female patients: a retrospective observational study
暂无分享,去创建一个
I. Shimomura | Y. Sakata | H. Nishizawa | N. Maeda | M. Higashi | Yuji Matsuzawa | J. Kozawa | H. Ozawa | Y. Fujita | M. Baden | Yuya Yamada | K. Saisho | S. Tamba | Koji Yamamoto | C. Ishibashi | Yoshiya Hosokawa | Ryuya Iwamoto | Ryohei Mineo | Takuya Sugiyama | S. Kawata | Sarasa Kato | Risa Kashiwagi-Takayama | Chisaki Ishibashi
[1] P. Guzzi,et al. Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance , 2023, Cardiovascular Diabetology.
[2] Oana M Aburel,et al. The Role and Implications of Epicardial Fat in Coronary Atherosclerotic Disease , 2022, Journal of clinical medicine.
[3] B. Bakker,et al. Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma , 2022, Frontiers in Cardiovascular Medicine.
[4] C. Enrich,et al. Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] S. Musani,et al. Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study , 2022, Cardiovascular Diabetology.
[6] Zahra Moghimi,et al. Lipids and diastolic dysfunction: Recent evidence and findings. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[7] Y. Chiao,et al. Age and Sex Differences in Heart Failure With Preserved Ejection Fraction , 2022, Frontiers in Aging.
[8] R. Marfella,et al. Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes , 2022, Biomolecules.
[9] F. Ng,et al. Epicardial adipose tissue as a mediator of cardiac arrhythmias , 2021, American journal of physiology. Heart and circulatory physiology.
[10] G. Paolisso,et al. Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts. , 2021, Metabolism: clinical and experimental.
[11] A. Vidal-Puig,et al. Lipotoxicity: a driver of heart failure with preserved ejection fraction? , 2021, Clinical science.
[12] I. Shimomura,et al. Ectopic Fat Accumulation in Pancreas and Heart , 2021, Journal of clinical medicine.
[13] G. Cho,et al. Association of pericardial adipose tissue with left ventricular structure and function: a region‐specific effect? , 2020, Cardiovascular Diabetology.
[14] R. D. de Boer,et al. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction , 2020, Cardiovascular research.
[15] S. Heymans,et al. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities , 2020, Basic Research in Cardiology.
[16] Filippo Cademartiri,et al. Validity of epicardial fat volume as biomarker of coronary artery disease in symptomatic individuals: Results from the ALTER-BIO registry. , 2020, International journal of cardiology.
[17] G. Kararigas,et al. Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.
[18] I. Shimomura,et al. Intractable Coronary Artery Disease in a Patient With Type 2 Diabetes Presenting With Triglyceride Deposit Cardiomyovasculopathy , 2019, Diabetes Care.
[19] Quincy A. Hathaway,et al. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. , 2019, American journal of physiology. Endocrinology and metabolism.
[20] N. Schiller,et al. Mitral annular peak systolic and diastolic velocities are characteristic of healthy hearts: A Doppler tissue imaging study , 2018, Echocardiography.
[21] C. Vrints,et al. Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model , 2017, Circulation. Heart failure.
[22] Sanjiv J. Shah,et al. A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure. , 2017, Journal of the American College of Cardiology.
[23] Y. Kodama,et al. Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study , 2016, Diabetes Care.
[24] S. Ng,et al. Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure , 2015, Journal of Cardiovascular Magnetic Resonance.
[25] S. Hamada,et al. Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase. , 2015, International journal of cardiology.
[26] Gianluca Iacobellis,et al. Local and systemic effects of the multifaceted epicardial adipose tissue depot , 2015, Nature Reviews Endocrinology.
[27] D. Rhee,et al. Effects of the difference in tube voltage of the CT scanner on dose calculation , 2015, 1503.03563.
[28] J. Meigs,et al. Links Between Ectopic Fat and Vascular Disease in Humans , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[29] M. Setou,et al. Coronary triglyceride deposition in contemporary advanced diabetics , 2014, Pathology international.
[30] Yoo-Seok Yoon,et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. , 2014, Radiology.
[31] Roy Taylor. Type 2 Diabetes , 2013, Diabetes Care.
[32] K. Clément,et al. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat , 2012, International Journal of Obesity.
[33] Ali Guermazi,et al. Changes in paraspinal muscles and their association with low back pain and spinal degeneration: CT study , 2010, European Spine Journal.
[34] S. Toda,et al. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.
[35] Jeroen J. Bax,et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.
[36] Benjamin D. Levine,et al. Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.
[37] S. Park,et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. , 2007, Radiology.
[38] I. Lemieux,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[39] Sang Won Lee,et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.
[40] G. Metzger,et al. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.
[41] Jeffrey C. Hill,et al. Influence of age on assessment of diastolic function by Doppler tissue imaging. , 2003, The American journal of cardiology.
[42] B. Goodpaster,et al. Composition of Skeletal Muscle Evaluated with Computed Tomography , 2000, Annals of the New York Academy of Sciences.
[43] S. Yamashita,et al. Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.
[44] T. Toda,et al. Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy. , 2018, Biochemical and biophysical research communications.
[45] Chisayo Kozuka,et al. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome. , 2013, Internal medicine.
[46] R. Califf,et al. Metabolic syndrome: definition, pathophysiology, and mechanisms. , 2005, American heart journal.
[47] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[48] M. Winker,et al. Age and the cardiovascular system. , 1993, The New England journal of medicine.